Prevalence of single-nucleotide variants in twenty-five pharmacogenes from a Cuban sample cohort
Altogether, our results may support national strategies for the introduction of pharmacogenetic tools in clinical practice, contributing to the development of precision medicine in Cuba.
Authors
- Zhiv Shkedy
- Miguel David Fernández-Pérez
- Elizabeth Cuétara-Lugo
- Dirk Valkenborg (ORCID: https://orcid.org/0000-0002-1877-3496)
- Gisselle Fernández (ORCID: https://orcid.org/0000-0002-5339-8118)
- Wim Vandenberghe (ORCID: https://orcid.org/0000-0002-9758-5062)
- Claudina Pérez-Novo (ORCID: https://orcid.org/0000-0003-4562-4346)
- J. Herrera (ORCID: https://orcid.org/0000-0003-2244-7180)
- Elizabeth Reyes-Reyes
- Idania González-Pérez
- Idania Rodeiro-Guerra
Institutions
- University of Antwerp (BE)
- University of Havana (CU)
- Cuban Neuroscience Center (CU)
- Instituto de Oncología y Radiobiología (CU)
- Instituto de Cibernética Matemática y Física (CU)
- Hasselt University (BE)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3389/fphar.2024.1467036
- Citations
- 2
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- Global Environment Fund
- VLIRUOS